Table 6.
Peripheral Sensitization | Central Sensitization | Peripheral and Central Sensitization | No Sensitization | p-value | |
---|---|---|---|---|---|
Method 1
|
|||||
Age (years) | 32.1 [26.1; 38.1] | 32.4 [25.3; 39.4] | 34.6 [28.3; 40.9] | 27.3 [21.6; 33.0] | 0.389 |
Sex (%females) | 14.3 [2.8; 41.2] | 45.5 [21.3; 72.0] | 35.0 [18.0; 56.8] | 16.7 [3.5; 46.0] | 0.239 |
Pain duration (weeks) | 82.3 [20.4; 144.4] | 108.4 [48.4; 168.3] | 67.7 [45.3; 90.1] | 28.9 [6.6; 51.2] | 0.080 |
Pain intensity (x/10) | 3.0 [1.7; 4.3] | 3.8 [2.2; 5.5] | 3.5 [2.6; 4.5] | 2.5 [1.3; 3.6] | 0.392 |
FPQ-9 | 19.5 [16.7; 22.3] | 19.3 [16.4; 22.2] | 23.3 [20.2; 26.4] | 20.1 [17.0; 23.1] | 0.120 |
PCS | 9.3 [5.6; 13.0] | 13.8 [6.8; 21.0] | 13.3 [19.0; 17.5] | 11.2 [5.6; 16.7] | 0.503 |
TSK-11 | 23.7 [20.3; 27.2] | 25.5 [23.1; 27.8] | 26.0 [23.6; 28.3] | 23.6 [19.2; 28.0] | 0.537 |
Method 2
|
|||||
Age (years) | 32.8 [27.2; 38.3] | 28.4 [21.1; 35.7] | 33.5 [25.9; 41.1] | 31.4 [25.3; 37.4] | 0.762 |
Sex (%females) | 20.0 [7.5; 42.2] | 50.0 [21.5; 78.5] | 30.8 [12.4; 58.0] | 21.4 [6.8; 48.3] | 0.401 |
Pain duration (weeks) | 83.6 [41.8; 125.3] | 110.4 [30.4; 190.3] | 56.3 [22.8; 89.8] | 46.5 [14.2; 78.8] | 0.212 |
Pain intensity (x/10) | 3.0 [2.1; 3.9] | 3.6 [1..2; 6.0] | 3.4 [2.1; 4.8] | 2.8 [1.7; 3.9] | 0.785 |
FPQ-9 | 22.1 [19.4; 24.7] | 21.1 [18.7; 23.5] | 20.5 [16.5; 24.6] | 18.9 [15.9; 22.0] | 0.449 |
PCS | 12.1 [8.6; 15.5] | 14.0 [3.5; 24.5] | 9.2 [4.8; 13.5] | 12.0 [7.6; 16.4] | 0.592 |
TSK-11 | 25.5 [23.1; 27.9] | 26.8 [22.2; 31.3] | 23.7 [20.3; 27.3] | 23.4 [20.3; 26.6] | 0.442 |
Values presented as % (for sex) or mean with [95% CI]. Method 1 is based on classification of PSI x CSI-PPT. Method 2 is based on classification of PSI x CSI-SHPR. Pain intensity is the average of pain reported currently, at least, and at worst.
Abbreviations: FPQ-9 – Fear of Pain Questionnaire, PCS – Pain Catastrophizing Scale, TSK-11 – Tampa Scale of Kinesiophobia.